Completed PHASE4 INTERVENTIONAL 2-arm NCT01441245

Loop Diuretics Administration and Acute Heart Failure (diurHF)

Continuous Versus Intermittent Loop Diuretics Infusion Dosing in Acute Heart Failure: Effects on Renal Function, Outcome and BNP Levels

Sponsor: University of Siena

Conditions Acute Heart Failure

Interventions furosemide infusion

Updated 11 times since 2017 Last updated: Dec 28, 2017 Started: Apr 30, 2010 Primary completion: Jun 30, 2016 Completion: Dec 28, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Heart Failure and is currently completed. University of Siena leads this study, which shows 11 recorded versions since 2010 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

11 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4

▶ Show 6 earlier versions

Dec 2021 — Dec 2022 [monthly]

Completed PHASE4
Jan 2021 — Dec 2021 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Aug 2017 — Feb 2018 [monthly]

Active Not Recruiting PHASE4
Jan 2017 — Aug 2017 [monthly]

Active Not Recruiting PHASE4

First recorded

Apr 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Siena

Data source: University of Siena

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Siena, Italy